Cilostazol reduces proliferation through c-Myc down-regulation in MDCK cells

European Journal of Pharmacology

Volumn 616, Issue 1-3, 2009, Pages 22-30

  Muñoz, Balam ^a   Huerta, Miriam ^a   López Bayghen, Esther ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

c Myc; Cell proliferation; Cilostazol; Polycystic kidney disease

Indexed keywords

CILOSTAZOL; DNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYC PROTEIN;

ANIMAL CELL; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG EXPOSURE; DRUG RESPONSE; GENETIC TRANSCRIPTION; KIDNEY CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; TRANSCRIPTION REGULATION;

ANIMALS; APOPTOSIS; BASE SEQUENCE; CELL CYCLE; CELL LINE; CELL PROLIFERATION; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DISEASE PROGRESSION; DNA; DOGS; DOWN-REGULATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; PHOSPHODIESTERASE INHIBITORS; POLYCYSTIC KIDNEY DISEASES; PROTO-ONCOGENE PROTEINS C-MYC; TETRAZOLES; TRANSCRIPTION FACTORS;

EID: 67651093802     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.06.016     Document Type: Article

References (53)

1. Adhikary S., and Eilers M. Transcriptional regulation and transformation by Myc proteins. Nature Reviews 6 (2005) 635-645
2. Advani S.J., Weichselbaum R.R., and Roizman B. E2F proteins are posttranslationally modified concomitantly with a reduction in nuclear binding activity in cells infected with herpes simplex virus 1. Journal of Virology 74 (2000) 7842-7850
3. Alvarez E., Northwood I.C., Gonzalez F.A., Latour D.A., Seth A., Abate C., Curran T., and Davis R.J. Pro-Leu-Ser/Thr-Pro is a consensus primary sequence for substrate protein phosphorylation. Characterization of the phosphorylation of c-myc and c-jun proteins by an epidermal growth factor receptor threonine 669 protein kinase. The Journal of Biological Chemistry 266 (1991) 15277-15285
4. Baek W.K., Park J.W., Lim J.H., Suh S.I., Suh M.H., Gabrielson E., and Kwon T.K. Molecular cloning and characterization of the human budding uninhibited by benomyl (BUB3) promoter. Gene 295 (2002) 117-123
5. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72 (1976) 248-254
6. Cowley Jr. B.D., Smardo Jr. F.L., Grantham J.J., and Calvet J.P. Elevated c-myc protooncogene expression in autosomal recessive polycystic kidney disease. Proceedings of the National Academy of Sciences of the United States of America 84 (1987) 8394-8398
7. Chen T.C., Hinton D.R., Zidovetzki R., and Hofman F.M. Up-regulation of the cAMP/PKA pathway inhibits proliferation, induces differentiation, and leads to apoptosis in malignant gliomas. Laboratory Investigation; A Journal of Technical Methods and Pathology 78 (1998) 165-174
8. Cheng J., and Grande J.P. Cyclic nucleotide phosphodiesterase (PDE) inhibitors: novel therapeutic agents for progressive renal disease. Experimental Biology and Medicine (Maywood, N.J 232 (2007) 38-51
9. Cheng J., Thompson M.A., Walker H.J., Gray C.E., Diaz Encarnacion M.M., Warner G.M., and Grande J.P. Differential regulation of mesangial cell mitogenesis by cAMP phosphodiesterase isozymes 3 and 4. Am J Physiol Renal Physiol 287 (2004) F940-953
10. Cheng J., Thompson M.A., Walker H.J., Gray C.E., Warner G.M., Zhou W., and Grande J.P. Lixazinone stimulates mitogenesis of Madin-Darby canine kidney cells. Experimental Biology and Medicine (Maywood, N.J 231 (2006) 288-295
11. Dalainas I. Cilostazol in the management of vascular disease. International Angiology 26 (2007) 1-7
12. Dang C.V., O'Donnell K.A., Zeller K.I., Nguyen T., Osthus R.C., and Li F. The c-Myc target gene network. Seminars in Cancer Biology 16 (2006) 253-264
13. Gaal K., and Forgacs I. Interaction of cAMP and adrenoreceptors on regulation of renal function and renin secretion. Acta physiologica Academiae Scientiarum Hungaricae 49 (1977) 111-118
14. Gattone II V.H. Emerging therapies for polycystic kidney disease. Current Opinion in Pharmacology 5 (2005) 535-542
15. Gohler T., Reimann M., Cherny D., Walter K., Warnecke G., Kim E., and Deppert W. Specific interaction of p53 with target binding sites is determined by DNA conformation and is regulated by the C-terminal domain. The Journal of Biological Chemistry 277 (2002) 41192-41203
16. Gregory M.A., and Hann S.R. c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells. Molecular and Cellular Biology 20 (2000) 2423-2435
17. Harding M.A., Gattone II V.H., Grantham J.J., and Calvet J.P. Localization of overexpressed c-myc mRNA in polycystic kidneys of the cpk mouse. Kidney International 41 (1992) 317-325
18. Herber B., Truss M., Beato M., and Muller R. Inducible regulatory elements in the human cyclin D1 promoter. Oncogene 9 (1994) 2105-2107
19. Huerta M., Munoz R., Tapia R., Soto-Reyes E., Ramirez L., Recillas-Targa F., Gonzalez-Mariscal L., and Lopez-Bayghen E. Cyclin D1 is transcriptionally down-regulated by ZO-2 via an E box and the transcription factor c-Myc. Molecular Biology of the Cell 18 (2007) 4826-4836
20. Ibraghimov-Beskrovnaya O. Targeting dysregulated cell cycle and apoptosis for polycystic kidney disease therapy. Cell cycle (Georgetown, Tex 6 (2007) 776-779
21. Ishikawa K., Ishii H., Murakumo Y., Mimori K., Kobayashi M., Yamamoto K., Mori M., Nishino H., Furukawa Y., and Ichimura K. Rad9 modulates the P21WAF1 pathway by direct association with p53. BMC Molecular Biology 8 (2007) 37
22. Kawanaka H., Tomikawa M., Baatar D., Jones M.K., Pai R., Szabo I.L., Sugimachi K., Sarfeh I.J., and Tarnawski A.S. Despite activation of EGF-receptor-ERK signaling pathway, epithelial proliferation is impaired in portal hypertensive gastric mucosa: relevance of MKP-1, c-fos, c-myc, and cyclin D1 expression. Life Sciences 69 (2001) 3019-3033
23. Kim M.J., Park K.G., Lee K.M., Kim H.S., Kim S.Y., Kim C.S., Lee S.L., Chang Y.C., Park J.Y., Lee K.U., and Lee I.K. Cilostazol inhibits vascular smooth muscle cell growth by downregulation of the transcription factor E2F. Hypertension 45 (2005) 552-556
24. Kohda N., Tani T., Nakayama S., Adachi T., Marukawa K., Ito R., Ishida K., Matsumoto Y., and Kimura Y. Effect of cilostazol, a phosphodiesterase III inhibitor, on experimental thrombosis in the porcine carotid artery. Thrombosis Research 96 (1999) 261-268
25. Kuramoto N., Ogita K., and Yoneda Y. Gene transcription through Myc family members in eukaryotic cells. Japanese Journal of Pharmacology 80 (1999) 103-109
26. Lee T., Yao G., Nevins J., and You L. Sensing and integration of Erk and PI3K signals by Myc. PLoS Computational Biology 4 (2008) e1000013
27. Liu Y., Shakur Y., Yoshitake M., and Kambayashi Ji J. Cilostazol (pletal): a dual inhibitor of cyclic nucleotide phosphodiesterase type 3 and adenosine uptake. Cardiovascular Drug Reviews 19 (2001) 369-386
28. Marampon F., Ciccarelli C., and Zani B.M. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors. Molecular Cancer 5 (2006) 31
29. Martinez J.R., and Grantham J.J. Polycystic kidney disease: etiology, pathogenesis, and treatment. Dis Mon 41 (1995) 693-765
30. Matousovic K., Grande J.P., Chini C.C., Chini E.N., and Dousa T.P. Inhibitors of cyclic nucleotide phosphodiesterase isozymes type-III and type-IV suppress mitogenesis of rat mesangial cells. The Journal of Clinical Investigation 96 (1995) 401-410
31. Matousovic K., Tsuboi Y., Walker H., Grande J.P., and Dousa T.P. Inhibitors of cyclic nucleotide phosphodiesterase isozymes block renal tubular cell proliferation induced by folic acid. The Journal of Laboratory and Clinical Medicine 130 (1997) 487-495
32. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65 (1983) 55-63
33. Nicotera P., Leist M., and Ferrando-May E. Apoptosis and necrosis: different execution of the same death. Biochemical Society Symposia 66 (1999) 69-73
34. Pintus G., Tadolini B., Posadino A.M., Sanna B., Debidda M., Bennardini F., Sava G., and Ventura C. Inhibition of the MEK/ERK signaling pathway by the novel antimetastatic agent NAMI-A down regulates c-myc gene expression and endothelial cell proliferation. European Journal of Biochemistry/FEBS 269 (2002) 5861-5870
35. Reisman D., Elkind N.B., Roy B., Beamon J., and Rotter V. c-Myc trans-activates the p53 promoter through a required downstream CACGTG motif. Cell Growth & Differentiation 4 (1993) 57-65
36. Ricker J.L., Mata J.E., Iversen P.L., and Gattone V.H. c-myc antisense oligonucleotide treatment ameliorates murine ARPKD. Kidney International 61 Suppl 1 (2002) 125-131
37. Salghetti S.E., Kim S.Y., and Tansey W.P. Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc. EMBO Journal 18 (1999) 717-726
38. Sarkar S.A., and Sharma R.P. Expression of c-Myc and other apoptosis-related genes in Swiss Webster mouse fetuses after maternal exposure to all trans-retinoic acid. Reproductive Toxicology 16 (2002) 245-252
39. Sears R., Ohtani K., and Nevins J.R. Identification of positively and negatively acting elements regulating expression of the E2F2 gene in response to cell growth signals. Molecular and Cellular Biology 17 (1997) 5227-5235
40. Sen R., and Baltimore D. Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell 47 (1986) 921-928
41. Stork P.J., and Schmitt J.M. Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends in Cell Biology 12 (2002) 258-266
42. Tamaoki T., Nomoto H., Takahashi I., Kato Y., Morimoto M., and Tomita F. Staurosporine, a potent inhibitor of phospholipid/Ca++ dependent protein kinase. Biochemical and Biophysical Research Communications 135 (1986) 397-402
43. Telfer J.F., Urquhart J., and Crouch D.H. Suppression of MEK/ERK signalling by Myc: role of Bin-1. Cellular Signalling 17 (2005) 701-708
44. Thierry F., Spyrou G., Yaniv M., and Howley P. Two AP1 sites binding JunB are essential for human papillomavirus type 18 transcription in keratinocytes. Journal of Virology 66 (1992) 3740-3748
45. Torres V.E., and Harris P.C. Polycystic kidney disease: genes, proteins, animal models, disease mechanisms and therapeutic opportunities. Journal of Internal Medicine 261 (2007) 17-31
46. Trudel M., D'Agati V., and Costantini F. C-myc as an inducer of polycystic kidney disease in transgenic mice. Kidney International 39 (1991) 665-671
47. Trudel M., Chretien N., and D'Agati V. Disappearance of polycystic kidney disease in revertant c-myc transgenic mice. Mammalian Genome 5 (1994) 149-152
48. Trudel M., Barisoni L., Lanoix J., and D'Agati V. Polycystic kidney disease in SBM transgenic mice: role of c-myc in disease induction and progression. The American Journal of Pathology 152 (1998) 219-229
49. Wang X., Gattone II V., Harris P.C., and Torres V.E. Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat. Journal of the American Society of Nephrology 16 (2005) 846-851
50. Wang Z., Ge L., Wang M., and Carr B.I. Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway. Journal of Cellular Physiology 208 (2006) 133-140
51. Yamaguchi T., Pelling J.C., Ramaswamy N.T., Eppler J.W., Wallace D.P., Nagao S., Rome L.A., Sullivan L.P., and Grantham J.J. cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway. Kidney International 57 (2000) 1460-1471
52. Zamorano A., Mellstrom B., Vergara P., Naranjo J.R., and Segovia J. Glial-specific retrovirally mediated gas1 gene expression induces glioma cell apoptosis and inhibits tumor growth in vivo. Neurobiology of Disease 15 (2004) 483-491
53. Zelikovic I., and Wager-Miller J. CAMP-dependent protein kinase inhibits proline transport across the rat renal tubular brush border membrane. Bioscience Reports 21 (2001) 613-626